Screening and treating depressed patients. A comparison of two controlled citalopram trials across treatment settings: Hospitalized patients vs. patients treated by their family doctors

Acta Psychiatrica Scandinavica

Volumn 94, Issue 1, 1996, Pages 18-25

  Fuglum, E ^a   Rosenberg, C ^b   Damsbo, N ^c   Stage, K ^d   Lauritzen, L ^e   Bech, P ^a,e   Gram, L F ^a   Kragh Sorensen P ^a   Bolwig, T G ^a   Vestergaard, P ^a   Reisby, N ^a  

^a Lægehuset ^*

^b Odense University Hospital ^*  (Denmark)

^c Lægehuset   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e FREDERIKSBORG GENERAL HOSPITAL   (Denmark)

Author keywords

Citalopram; Clomipramine; Imipramine; Rating scale; Selective serotonin reuptake inhibitors

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; IMIPRAMINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG COMPARISON; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SWEATING; TACHYCARDIA; TREMOR; VERTIGO; XEROSTOMIA;

EID: 8944224539     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1996.tb09819.x     Document Type: Article

References (29)

1. KUHN R. The treatment of depressive states with G22355 (imipramine hydrochloride). Am J Psychiatry 1958: 115: 459-464.
2. BALL JRB, KILOH LG. A controlled trial of imipramine in treatment of depressive states. Br Med J 1959: 2: 1052-1055.
3. ROBIN AA, LANGLEY GE. A controlled trial of imipramine. Br J Psychiatry 1964: 110: 419-422.
4. ANGST J, THEOBALL W, HERRMANN B, THOMANN PE. Tofranil (imipramine). Berne: Stämpfi and Cie, 1970.
5. PORTER AMW. Depressive illness in a general practice. A demographic study and a controlled trial of imipramine. Br Med J 1970: 1: 773-778.
6. BECH P. Rating scales for psychopathology, health status and quality of life: a comparison on documentation in accordance with the DSM-III-R and WHO systems. Berlin: Springer, 1993.
7. Paykel ES. Use of the Hamilton Depression Scale in general practice. In: BECH P, COPPEN A, ed. The Hamilton Scales. Berlin: Springer, 1990: 40-47.
8. BECH P. Acute therapy of depression. J Clin Psychiatry 1993: 54(Suppl. 8): 18-27.
9. GOTTLIEB P, WANDALL T, OVERØ KF. Initial clinical trial of a new specific 5-HT reuptake inhibitor, citalopram (Lu 10-171). Acta Psychiatr Scand 1980: 62: 236-244.
10. DE WILDE J, MERTENS C, OVER KF, PETERSEN HEH. Citalopram versus mianserin. Acta Psychiatr Scand 1985: 72: 89-96.
11. Danish University Antidepressant Group (DUAG). Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology 1986: 90: 131-138.
12. BECH P. Clinical effects of selective serotonin reuptake inhibitors. In: DAHL SG, GRAM LF, ed. Clinical pharmacology in psychiatry. Berlin: Springer, 1989: 81-93.
13. Bech P, Cialdella P. Citalopram in depression: meta-analysis of intended and unintended effects. Int Clin Psychopharmacol 1992: 6 (Suppl. 5): 45-54.
14. ROSENBERG C, DAMSBO N, FUGLUM E, JACOBSEN LV, HORSGÅRD S. Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study. Int Clin Psychopharmacol 1994: 9 (Suppl. 1): 41-48.
15. BECH P, ALLERUP P, GRAM LF et al. The Diagnostic Melancholia Scale (DSM). Dimensions of endogenous and reactive depression with relationship to the Newcastle Scales. J Affect Dis 1988: 14: 161-170.
16. BECH P, KASTRUP M, RAFAELSEN OJ. Mini-compendium of rating scales. Acta Psychiatr Scand 1986: 73 (Suppl. 326): 7-37.
17. LINGJÆRDE O, AHLFORS UG, BECH P, DENCKER SJ, ELGEN K. The UKU side effect rating scale. Acta Psychiatr Scand 1987: 76 (Suppl. 334): 1-100.
18. BARTKO JJ, CARPENTER WT. On the methods and theory of reliability. J Nerv Ment Dis 1976: 163: 307-317.
19. BECH P, GASTPAR M, MENDLEWICZ J. The role of training courses in multicenter trials: WHO experiences. In: CHAGAS C et al., ed. Developments in psychiatry Amsterdam: Elsevier, 1986: 1513-1515.
20. CHILD D. The essentials of factor analysis. London: Cassel, 1990.
21. BECH P. The Bech, Hamilton and Zung Scales for mood disorders: screening and listening. A twenty-year update with reference to DSM-IV and ICD-10. Berlin: Springer, 1995.
22. STASSEN HH, ANGST J, DELINI-STULA A. Severity at baseline and onset of improvement in depression. Meta-analysis of imipramine and moclobemide versus placebo. Eur Psychiatry 1994: 9: 129-136.
23. KUHN R. The imipramine story. In: AYD FJ, BALCKWELL B, ed. Discovery in biological psychiatry. Philadelphia: Lippincott, 1970: 205-217.
24. MONTGOMERY SA, PEDERSEN V, TANGHJ P, RASMUSSEN C, RIOUX P. The optimal dosing regimen for citalopram - a meta-analysis of nine placebo-controlled studies. Int J Clin Psychopharmacol 1994: 9 (Suppl. 1): 35-40.
25. PORTER R. Is Dr Feelgood here to stay? Times Lit Suppl: 25 March 1994: 28.
26. AZIMA H. Psychodynamic and psychotherapeutic problems in connection with imipramine (tofranil) intake. J Ment Sci 1961: 107: 74-82.
27. PRESKORN SH. Outpatient management of depression. New York: Professional Communications, 1994.
28. WATTS CAH. Depressive disorders in the community. Bristol: John Wright, 1966.
29. Clinical Practice Guideline. Depression in primary care, Vol. 2. Treatment of major depression. Rockville, MD: Agency for Health Care Policy and Research, 1993.